Advertisement

Index by author

September 01, 1988; Volume 34,Issue 3

  1. Adamik, R

    1. Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
      J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello
      Molecular Pharmacology September 1988, 34 (3) 279-285;

  2. Antkiewicz-michaluk, L

    1. Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands.
      L Antkiewicz-Michaluk, A Guidotti and K E Krueger
      Molecular Pharmacology September 1988, 34 (3) 272-278;

  3. Artymyshyn, R P

    1. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
      G R Luthin, J Harkness, R P Artymyshyn and B B Wolfe
      Molecular Pharmacology September 1988, 34 (3) 327-333;

  4. Bahouth, S W

    1. Subclassification of beta-adrenergic receptors of rat fat cells: a re-evaluation.
      S W Bahouth and C C Malbon
      Molecular Pharmacology September 1988, 34 (3) 318-326;

  5. Bonhaus, D W

    1. N-methyl-D-aspartate receptor regulation of uncompetitive antagonist binding in rat brain membranes: kinetic analysis.
      D W Bonhaus and J O McNamara
      Molecular Pharmacology September 1988, 34 (3) 250-255;

  6. Borden, L A

    1. Mechanism of gamma-aminobutyric acid/benzodiazepine receptor turnover in neuronal cells: evidence for nonlysosomal degradation.
      L A Borden and D H Farb
      Molecular Pharmacology September 1988, 34 (3) 354-362;

  7. Camerman, A

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

  8. Camerman, N

    1. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
      G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
      Molecular Pharmacology September 1988, 34 (3) 363-376;

  9. Chen, J

    1. Dihydropyridine Bay K 8644 activates T lymphocyte calcium-permeable channels.
      W Young, J Chen, F Jung and P Gardner
      Molecular Pharmacology September 1988, 34 (3) 239-244;

  10. Clark, J A

    1. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
      J A Clark, R Houghten and G W Pasternak
      Molecular Pharmacology September 1988, 34 (3) 308-317;
« Previous (Pages : 1 2 3 4 5 6 ... 9) Next »
Back to top

In this issue

Advertisement